FORWARD PHARMA A/S

FWP
Delayed Quote. Delayed  - 09/29 03:55:11 pm
3.1USD +1.64%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Forward Pharma A/S is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark.

Number of employees : 4 people.
Managers
Name Title
Claus Bo Svendsen CEO & Principal Financial Officer
Florian Schönharting Director
Grant Hellier Lawrence Independent Director
Duncan Charles Mcnaught Moore Independent Director
Torsten Rüdiger Goesch Director
Jakob Mosegaard Larsen Director
Thomas Carbone Principal Accounting Officer & VP-Finance
Shareholders
Name Equities %
BVF Partners LP 513,791 7.25%
The Baupost Group LLC 406,857 5.74%
Newtyn Management LLC 340,599 4.80%
Morgan Stanley & Co. LLC 182,582 2.57%
Assured Investment Management LLC 180,890 2.55%
Mason Capital Management LLC 150,217 2.12%
RA Capital Management LP 138,657 1.96%
OrbiMed Advisors Private Equity 114,000 1.61%
Senzar Asset Management LLC 93,214 1.31%
Cormorant Asset Management LP 84,168 1.19%
Company contact information
Forward Pharma A/S
Østergade 24A
1st Floor
Copenhagen, Capital Region 1100

Phone : +45.33.44.42.42
Web : http://www.forward-pharma.com
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
FORWARD PHARMA A/S-48.07%22
GILEAD SCIENCES, INC.-11.95%80 128
REGENERON PHARMACEUTICALS, INC.11.70%75 415
VERTEX PHARMACEUTICALS33.16%74 991
BIONTECH SE-48.10%32 514
WUXI APPTEC CO., LTD.-38.82%28 423
GENMAB A/S-5.29%21 061
ARGENX SE16.30%19 471
BEIGENE, LTD.-47.43%14 760
NEUROCRINE BIOSCIENCES, INC.19.01%9 835
SAREPTA THERAPEUTICS, INC.22.05%9 625
KARUNA THERAPEUTICS, INC.72.23%7 545
LEGEND BIOTECH CORPORATION-13.41%6 756
ASCENDIS PHARMA A/S-23.22%5 769
HALOZYME THERAPEUTICS, INC.0.10%5 546
EXELIXIS, INC.-11.43%5 210
CYTOKINETICS, INCORPORATED8.01%4 710
PHARMAESSENTIA CORPORATION72.35%4 589
CEREVEL THERAPEUTICS HOLDINGS, INC.-13.63%4 361
INTRA-CELLULAR THERAPIES, INC.-13.34%4 282
BIOCON LIMITED-22.10%4 146
Brand Portfolio
» More brands of Forward Pharma A/S